Aehr Test Systems (AEHR) Revenue Forecast Misrepresentation Case

• $AEHR investors sued Aehr Test Systems for misleading them about revenue forecasts and customer order delays.

• On March 25, 2024, Aehr announced disappointing Q3 results and lowered its full-year revenue forecast to $65 million. Following this news, $AEHR fell by 22.44%.

• $AEHR investors can join this case to be notified about potential recovery.

Case Details:

In October 2023, Aehr provided optimistic revenue guidance for fiscal 2024, forecasting at least $100 million in revenue.

On January 9, 2024, during the Q2 earnings call, Aehr reduced its forecast to $75–$85 million, citing delays in new customer orders.

Despite this, CEO Gayn Erickson reassured investors of "very good visibility" into customer orders and confidence in achieving the revised forecast.

On March 25, 2024, Aehr reported Q3 revenue of $7.6 million, far below the $14.32 million estimate, and lowered its fiscal 2024 revenue forecast to $65 million.

The company attributed the shortfall to delays in semiconductor system orders tied to electric vehicle production, signaling more serious issues than previously disclosed.

This announcement caused the $AEHR by 22.44%.

Based on these events, $AEHR investors filed a lawsuit against Aehr Test Systems, accusing the company of the following:

• It misled investors about its revenue forecast and the extent of customer order delays.

• It downplayed challenges affecting its financial performance.

Investors believe Aehr misled them about revenue forecasts and customer order delays.